| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 4.237 | 16.470 | 42.651 | 59.125 | 58.125 |
| Total Income - EUR | - | - | - | - | - | 4.237 | 16.470 | 42.651 | 59.125 | 58.125 |
| Total Expenses - EUR | - | - | - | - | - | 2.911 | 9.100 | 25.903 | 36.960 | 43.434 |
| Gross Profit/Loss - EUR | - | - | - | - | - | 1.326 | 7.370 | 16.747 | 22.165 | 14.691 |
| Net Profit/Loss - EUR | - | - | - | - | - | 1.203 | 6.876 | 15.756 | 21.573 | 12.947 |
| Employees | - | - | - | - | - | 1 | 1 | 2 | 2 | 2 |
Check the financial reports for the company - Native-Derma S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 0 | 0 | 24.939 | 20.968 | 17.872 |
| Current Assets | - | - | - | - | - | 1.579 | 8.327 | 21.427 | 42.862 | 8.685 |
| Inventories | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | 0 | 0 | 0 | 0 | 422 |
| Cash | - | - | - | - | - | 1.579 | 8.327 | 21.427 | 42.862 | 8.263 |
| Shareholders Funds | - | - | - | - | - | 1.244 | 8.092 | 23.874 | 45.375 | 12.992 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | 335 | 235 | 22.493 | 18.456 | 13.566 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Native-Derma S.r.l.